Search Results 231-240 of 8339 for Venlafaxine

  1. Flavocoxid (oral route) - Side effects & dosage - Mayo Clinic

    Flavocoxid is used to treat moderate to severe symptoms of osteoarthritis. This medicine is used in patients 18 years of age or older. Flavocoxid will not cure ...

  2. Hexaminolevulinate (urinary bladder route) - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  3. Gadoterate (intravenous route) - Mayo Clinic

    Gadoterate injection is used a magnetic resonance imaging (MRI) contrast agent used to help create a clear picture of the body during an MRI scan. MRI scans use ...

  4. Doctors & Departments - Mayo Clinic

    Research. Mayo Clinic researchers conduct studies involving complementary and integrative medicine to learn which treatments and therapies work and to share ...

  5. Efavirenz, emtricitabine, and tenofovir (oral route) - Side effects & dosage - Mayo Clinic

    Efavirenz, emtricitabine, and tenofovir combination is used alone or with other anti-HIV medicines to treat human immunodeficiency virus (HIV) infection. HIV is ...

  6. Treatment

    Cutaneous B-cell lymphoma treatment depends on the specific type of lymphoma that you have. Treatment options may include: Radiation therapy.

  7. Fexofenadine (oral route) - Side effects & dosage - Mayo Clinic

    Skip to content. Mayo Clinic Home Page. Care at Mayo Clinic. Patient-Centered Care · About Mayo Clinic · Request Appointment.

  8. Milnacipran (oral route) - Side effects & dosage - Mayo Clinic

    Milnacipran is used to treat a condition called fibromyalgia, which causes muscle pain and stiffness. It belongs to a group of medicines known as selective ...

  9. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    This pilot clinical trial studies how well buparlisib works in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.

  10. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors In Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts In Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) And Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

    BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors In Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts In Small Cell Lung Carcinoma ( ...